Skip to main content
MEDICLIN AG logo

MEDICLIN AG — Investor Relations & Filings

Ticker · MED ISIN · DE0006595101 LEI · 5299007ZHUSGAJRMWH73 F Human health and social work activities
Open in API
Filings indexed 527 across all filing types
Latest filing 2025-11-04 Earnings Release
Country DE Germany
Listing F MED

About MEDICLIN AG

https://www.mediclin.de/

MEDICLIN AG is an operator of healthcare facilities, providing medical services across a network of hospitals, rehabilitation clinics, nursing care homes, and outpatient medical centers. The company's core business is divided into three primary segments: acute care, post-acute care/rehabilitation, and nursing care. It offers specialized inpatient and outpatient treatment in numerous medical fields, including neurology, psychosomatics, orthopedics, internal medicine, cardiology, and oncology. MEDICLIN places a significant emphasis on rehabilitation, engaging in research and developing innovative therapeutic concepts. This includes specialized programs for conditions such as Post-COVID syndrome and a digital teletherapy platform, MEDICLIN HOME, for online rehabilitation.

Recent filings

Filing Released Lang Actions
MEDICLIN on track: business development in line with expectations
Earnings Release Classification · 100% confidence The document is a corporate news release announcing the 9-month financial results for MEDICLIN AG. It provides key highlights such as sales figures, operating results, and segment performance, and explicitly states that the full interim report is available on their website. Following the 'Menu vs Meal' rule, this is an announcement of financial results rather than the full interim report itself, making it an Earnings Release (ER). 9M 2025
2025-11-04 English
Quartalsfinanzbericht
Interim / Quarterly Report Classification · 100% confidence The document is a 'Zwischenbericht' (Interim Report) for MEDICLIN AG covering the period from January 1, 2025, to September 30, 2025. It contains detailed financial statements, including balance sheets, cash flow analysis, segment reporting, and management commentary on the financial performance. It is not an announcement of a report, but the report itself, and it provides substantive financial data, fitting the definition of an Interim/Quarterly Report (IR). 9M 2025
2025-11-04 German
Half-yearly financial report 2025
Interim / Quarterly Report Classification · 100% confidence The document is explicitly titled 'Interim report of MEDICLIN Aktiengesellschaft' and covers the period from 1 January 2025 to 30 June 2025. It contains detailed financial statements, including balance sheets, cash flow data, and management analysis of the results of operations. This meets the criteria for an Interim/Quarterly Report (IR) as it provides substantive financial data and analysis for a period shorter than a full fiscal year. H1 2025
2025-08-18 English
MEDICLIN reports positive interim results for the first half of 2025
Earnings Release Classification · 100% confidence The document is a corporate news release announcing the interim financial results for the first half of 2025. It provides key highlights such as group operating results, sales figures, and segment performance, but explicitly states at the end that the full interim report is available on the company's website. Following the 'Menu vs Meal' rule, this is an announcement of a report rather than the report itself, classifying it as an Earnings Release (ER). H1 2025
2025-07-31 English
Halbjahresfinanzbericht nach WpHG zum Geschäftsjahr vom 01.01.2025 bis zum 30.06.2025
Interim / Quarterly Report Classification · 100% confidence The document is a 'Halbjahresfinanzbericht' (Half-Year Financial Report) for MEDICLIN Aktiengesellschaft for the period from January 1, 2025, to June 30, 2025. It contains comprehensive financial statements, including balance sheets, cash flow analysis, income statements, and detailed management commentary on the financial and operational performance. As it covers a period shorter than a full fiscal year and provides substantive financial data, it is classified as an Interim/Quarterly Report. H1 2025
2025-07-31 German
Ergänzung der Veröffentlichung vom 28.04.2025
Notice of Dividend Amount Classification · 98% confidence The document explicitly mentions 'Jahres- und Konzernabschluss zum Geschäftsjahr vom 01.01.2024 bis zum 31.12.2024' (Annual and Consolidated Financial Statements for the fiscal year 2024) and details the 'BESCHLUSS ÜBER DIE ERGEBNISVERWENDUNG' (Resolution on the Appropriation of Profits), specifically announcing a dividend distribution based on the approved annual financial statements. Although it references the Annual Report (Jahresabschluss), the core content here is the formal decision regarding the distribution of profits/dividends following the approval of the annual results. This aligns best with the 'Notice of Dividend Amount' (DIV) category, as the primary actionable information is the dividend declaration based on the prior year's performance. The document length is short (1155 chars), but it contains the final resolution, not just an announcement that a report is available.
2025-07-14 German

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.